Viewing Study NCT05715918


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:59 AM
Study NCT ID: NCT05715918
Status: UNKNOWN
Last Update Posted: 2023-03-07
First Post: 2023-02-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 of Children at the Age of 12-17 Years Inclusive"
Sponsor: Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-04-01
Start Date Type: ACTUAL
Primary Completion Date: 2023-12-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-02-01
Completion Date Type: ESTIMATED
First Submit Date: 2023-02-06
First Submit QC Date: None
Study First Post Date: 2023-02-08
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-03-06
Last Update Post Date: 2023-03-07
Last Update Post Date Type: ACTUAL